Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer

IMPORTANCE: Unregulated drug prices increase cancer therapy costs. After induction chemotherapy, patients with metastatic colon cancer can receive maintenance capecitabine and bevacizumab therapy based on improved progression-free survival, but whether this treatment’s cost justifies its benefits ha...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:JAMA Oncol
Hoofdauteurs: Sherman, Scott K., Lange, Joel J., Dahdaleh, Fadi S., Rajeev, Rahul, Gamblin, T. Clark, Polite, Blase N., Turaga, Kiran K.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Medical Association 2018
Onderwerpen:
Original Investigation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6440196/
https://ncbi.nlm.nih.gov/pubmed/30489611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.5070
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items